Similasan Reisekrankheit, Tabletten
7680678130013
CH-67813
Tabletten
Associated product:
SIMILASAN Maux de voyage cpr 60 pce
1 / 3
google
Article details
- Package size
- 60
- Selling units
- 60
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
strychnos nux-vomica (HAB)
|
6.25 MG | Substance | Wirkstoff (Principe actif) |
|
hyoscyamus niger (HAB)
|
6.25 MG | Substance | Wirkstoff (Principe actif) |
|
petroleum rectificatum (HAB)
|
6.25 MG | Substance | Wirkstoff (Principe actif) |
|
anamirta cocculus (HAB)
|
6.25 MG | Substance | Wirkstoff (Principe actif) |
|
maydis amylum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
241.25 MG | Substance | HBESI |
Authorization holder
Similasan AG
8916 Jonen
Authorization information
- Swissmedic authorization number
- 67813
- Drug name
- Similasan Reisekrankheit, Tabletten
- Galenic form
- TAB
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 23/11/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 20.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- SIMILASAN Maux de voyage cpr 60 pce
- Description (DE)
- SIMILASAN Reisekrankheit Tabl 60 Stk
- Market launch
- 23/11/2021
- Narcotic (BTM)
- No